Elevated plasma IL-6 and CRP levels are associated with adverse clinical outcomes and death in critically ill SARS-CoV-2 patients: inflammatory response of SARS-CoV-2 patients
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Elevated plasma IL-6 and CRP levels are associated with adverse clinical outcomes and death in critically ill SARS-CoV-2 patients: inflammatory response of SARS-CoV-2 patients
Authors
Keywords
-
Journal
Annals of Intensive Care
Volume 11, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-01-13
DOI
10.1186/s13613-020-00798-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Epidemiologic Features and Clinical Course of Patients Infected With SARS-CoV-2 in Singapore
- (2020) Barnaby Edward Young et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China
- (2020) Dawei Wang et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
- (2020) Chaolin Huang et al. LANCET
- A pneumonia outbreak associated with a new coronavirus of probable bat origin
- (2020) Peng Zhou et al. NATURE
- Complex Immune Dysregulation in COVID-19 Patients with Severe Respiratory Failure
- (2020) Evangelos J. Giamarellos-Bourboulis et al. Cell Host & Microbe
- Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy
- (2020) Giacomo Grasselli et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Clinical and immunological features of severe and moderate coronavirus disease 2019
- (2020) Guang Chen et al. JOURNAL OF CLINICAL INVESTIGATION
- Elevated Interleukin‐6 and Severe COVID‐19: A Meta‐Analysis
- (2020) Muhammad Aziz et al. JOURNAL OF MEDICAL VIROLOGY
- IL-6–based mortality risk model for hospitalized patients with COVID-19
- (2020) Rocio Laguna-Goya et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Supportive Treatment with Tocilizumab for COVID-19: A Systematic Review
- (2020) Saeed K. Alzghari et al. JOURNAL OF CLINICAL VIROLOGY
- Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy
- (2020) Corrado Lodigiani et al. THROMBOSIS RESEARCH
- An inflammatory cytokine signature predicts COVID-19 severity and survival
- (2020) Diane Marie Del Valle et al. NATURE MEDICINE
- Cytokine elevation in severe and critical COVID-19: a rapid systematic review, meta-analysis, and comparison with other inflammatory syndromes
- (2020) Daniel E Leisman et al. Lancet Respiratory Medicine
- Role of C-Reactive Protein at Sites of Inflammation and Infection
- (2018) Nicola R. Sproston et al. Frontiers in Immunology
- The multifaceted role of fibrinogen in tissue injury and inflammation
- (2018) James P. Luyendyk et al. BLOOD
- Acute kidney disease and renal recovery: consensus report of the Acute Disease Quality Initiative (ADQI) 16 Workgroup
- (2017) Lakhmir S. Chawla et al. Nature Reviews Nephrology
- Middle East Respiratory Syndrome Coronavirus Efficiently Infects Human Primary T Lymphocytes and Activates the Extrinsic and Intrinsic Apoptosis Pathways
- (2015) Hin Chu et al. JOURNAL OF INFECTIOUS DISEASES
- Rapid generation of a mouse model for Middle East respiratory syndrome
- (2014) Jincun Zhao et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Isolation of a Novel Coronavirus from a Man with Pneumonia in Saudi Arabia
- (2012) Ali M. Zaki et al. NEW ENGLAND JOURNAL OF MEDICINE
- Kinetics of IL-6 and TNF-α changes in a canine model of sepsis induced by endotoxin
- (2012) Ruhui Song et al. VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started